Psyence Group is a biotechnology company focused on developing natural psilocybin-based solutions for mental health, particularly in the context of palliative care. The company is pioneering the use of natural psychedelics to address mental health disorders such as anxiety and depression. Psyence operates one of the first federally licensed and ISO22000 certified facilities for the cultivation and production of psilocybin, ensuring high standards in their processes. Their product offerings include medicinal formulations and treatment protocols designed for clinical environments, as well as functional mushroom wellness products that leverage the benefits of adaptogens, which are known for their stress-relieving properties.

The company is also involved in clinical research, with Psyence Biomedical, its NASDAQ-listed associate, conducting Phase IIb clinical trials to evaluate the efficacy of nature-derived psilocybin for adjustment disorders in palliative care settings. Psyence Group's team comprises experts in neurology and pharmaceutical product development, supported by a global executive team with extensive experience in capital markets and business growth. This combination of scientific expertise and business acumen positions Psyence Group as a leader in the emerging field of psychedelic medicine, aiming to create innovative and effective treatments for mental health challenges.

Canada

Psyence (PSYG) is a clinical-stage life science biotechnology company pioneering the use of natural psilocybin in mental health and well‑being. We have a focus on these conditions in the context of palliative care.


Psyence is listed on the Canadian Stock Exchange (CSE: PSYG) and on the US OTCQB® Venture Market (OTCQB: PSYGF). Our diversified business has a global footprint with operations in multiple legal jurisdictions. We operate one of the first federally licensed commercial psilocybin cultivation and production facilities in the world in Southern Africa. 

For more information: www.psyence.com

Psyence Group

Company Details